Protective effects of lemongrass (Cymbopogon citratus STAPF) essential oil on DNA damage and carcinogenesis in female Balb/C mice

Journal of Applied Toxicology

Volumn 31, Issue 6, 2011, Pages 536-544

  Bidinotto, Lucas T ^a   Costa, Celso A R A ^a   Salvadori, Daisy M F ^a   Costa, Mirtes ^a   Rodrigues, Maria A M ^a   Barbisan, Luís F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Anticarcinogenesis; Antigenotoxicity; Female Balb c mice; Lemongrass essential oil; Multiple organ carcinogenesis

Indexed keywords

1,2 DIMETHYLHYDRAZINE; ANTINEOPLASTIC AGENT; CYMBOPOGON CITRATUS EXTRACT; METHYLNITROSOUREA; N BUTYL N (4 HYDROXIBUTHYL)NITROSAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER; BREAST HYPERPLASIA; CANCER DIAGNOSIS; CARCINOGENESIS; COLON; COMET ASSAY; CONTROLLED STUDY; CYMBOPOGON CITRATUS; DNA DAMAGE; FEMALE; HISTOPATHOLOGY; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANTICARCINOGENESIS; ANTIGENOTOXICITY; FEMALE BALB/C MICE; LEMONGRASS ESSENTIAL OIL; MULTIPLE-ORGAN CARCINOGENESIS;

ANIMALS; CARCINOGENESIS; CARCINOGENICITY TESTS; CARCINOGENS; COLON; COMET ASSAY; DNA DAMAGE; ENDPOINT DETERMINATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MAMMARY GLANDS, ANIMAL; METHYLNITROSOUREA; MICE; MICE, INBRED BALB C; PLANT OILS; TERPENES; URINARY BLADDER;

ANIMALIA; CYMBOPOGON CITRATUS; MUS;

EID: 80051996127     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1593     Document Type: Article

References (64)

1. Adams RP. 2001. Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy, 3rd edn. Allured: Carol Stream, IL.
2. Aggarwal BB, Shishodia S. 2006. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71: 1397-1421.
3. Bannasch P, Nehrbass D, Kopp-Schneider A. 2001. Significance of hepatic preneoplasia for cancer chemoprevention. IARC Sci. Publ. 154: 223-240.
4. Bannasch P, Haertel T, Su Q. 2003. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol. Pathol. 31: 134-139.
5. Barbosa LC, Pereira UA, Martinazzo AP, Maltha CR, Teixeira RR, Melo Ede C. 2008. Evaluation of the chemical composition of Brazilian commercial Cymbopogon citratus (D.C.) stapf samples. Molecules 13: 1864-1874.
6. Bidinotto LT, Spinardi-Barbisan AL, Rocha NS, Salvadori DM, Barbisan LF. 2006. Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model. Environ. Mol. Mutagen. 47: 624-630.
7. Bird RP, Good CK. 2000. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol. Lett. 112-113: 395-402.
8. Blanco MM, Costa CARA, Freire AO, Santos Jr JG, Costa M. 2009. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine 16: 265-270.
9. Cardif RD, Wellings SR. 1999. The comparative pathology of human and mouse mammary glands. J. Mammary Gland Biol. Neoplasia 4: 105-122.
10. Carnesecchi S, Schneider Y, Ceraline J, Duranton B, Gosse F, Seiler N, Raul F. 2001. Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. J. Pharm. Exp. Ther. 298: 197-200.
11. Cheel J, Theoduloz C, Rodrguez J, Schmeda-Hirschmann G. 2005. Free radical scavengers and antioxidants from lemongrass (Cymbopogon citratus (DC.) Stapf.). J. Agric. Food Chem. 53: 2511-2517.
12. Choi H-S, Song HS, Ukeda H, Sawamura M. 2000. Radical-scavenging activities of citrus essential oils and their components: detection using 1, 1-diphenyl-2-picrylhydrazyl. J. Agric. Food Chem. 48: 4156-4161.
13. Cohen SM. 2002. Comparative pathology of proliferative lesions of the urinary bladder. Toxicol. Pathol. 30: 663-671.
14. Da Silva CB, Guterres SS, Weisbeimer V, Schapoval EES. 2008. Antifungal activity of the lemongrass oil and citral against Candida spp. Braz. J. Infect. Dis.12: 63-66.
15. De Flora S, Ferguson LR. 2005. Overview of mechanisms of cancer chemopreventive agents. Mutat. Res. 591: 8-15.
16. De Moura NA, Grassi TF, Rodrigues MA, Barbisan LF. 2010. Potential effects of the herbicide Diuron on mammary and urinary bladder two-stage carcinogenesis in a female Swiss mouse model. Arch. Toxicol. 84: 165-173.
17. Diliberto JJ, Srinivas P, Overstreet D, Usha G, Burka LT, Birnbaum LS. 1990. Metabolism of citral, an α, β-unsaturated aldehyde, in male F344 rats. Drug Metab. Dispos. 18: 866-875.
18. Doppalapudi RS, Riccio ES, Rausch LL, Shimon JA, Lee PS, Mortelmans KE, Crowell JA, Mirsalis JC. 2007. Evaluation of chemopreventive agents for genotoxic activity. Mutat. Res. 629: 148-160.
19. Duarte MC, Leme EE, Delarmelina C, Soares AA, Figueira GM, Sartoratto A. 2007. Activity of essential oils from Brazilian medicinal plants on Escherichia coli. J. Ethnopharmacol. 111: 197-201.
20. Duncan RE, Lau D, El-Sohemy A, Archer MC. 2004. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem. Pharmacol. 68: 1739-1747.
21. Fandohan P, Gnonlonfin B, Laleye A, Gbenou JD, Darboux R, Moudachirou M. 2008. Toxicity and gastric tolerance of essential oils from Cymbopogon citratus, Ocimum gratissimum and Ocimum basilicum in Wistar rats. Food Chem. Toxicol. 46: 2493-2497.
22. Feo F, Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi D. 2000. Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit. Rev. Oncol. 11: 19-62.
23. Ferguson LR, Philpott M, Karunasinghe N. 2004. Dietary cancer and prevention using antimutagens. Toxicology 198: 147-159.
24. Gabriel U, Bolenz C, Michel MS. 2007. Experimental models for therapeutic studies of transitional cell carcinoma. Anticancer Res. 27: 3163-3171.
25. Ganjewala D, Luthra R. 2010. Essential oil biosynthesis and regulation in the genus Cymbopogon. Nat. Prod. Commun. 5: 163-172.
26. Gomes-Carneiro MR, Felzenszwalb I, Paumgartten FJ. 1998. Mutagenicity testing (+/-)-camphor, 1, 8-cineole, citral, citronellal, (-)-menthol and terpineol with the Salmonella/microsome assay. Mutat. Res. 416(1-2): 129-136.
27. Hartmann A, Speit G. 1997. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett. 90: 183-188.
28. Hwang ES, Kim GH. 2007. Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 229: 1-10.
29. Irkin R, Korukluoglu M. 2009. Effectiveness of Cymbopogon citratus L. essential oil to inhibit the growth of some filamentous fungi and yeasts. J. Med. Food. 12: 193-197.
30. Kauderer B, Zamith H, Paumgartten FJ, Speit G. 1991. Evaluation of the mutagenicity of beta-myrcene in mammalian cells in vitro. Environ. Mol. Mutagen. 18: 28-34.
31. Khan N, Afaq F, Mukhtar H. 2008. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox. Signal 10: 475-510.
32. Loeb LA, Harris CC. 2008. Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res. 68: 6863-6872.
33. McLafferty FW, Stauffer D. 1989. The Wiley/NBS Registry of Mass Spectral Data. Wiley: New York.
34. Medina D. 2002. Biological and molecular characteristics of the premalignant mouse mammary gland. Biochim. Biophys. Acta 1603: 1-9.
35. Mehta RG. 2000. Experimental basis for the prevention of breast cancer. Eur. J. Cancer. 36: 1275-1282.
36. Melo SF, Soares SF, da Costa RF, da Silva CR, de Oliveira MB, Bezerra RJ, Caldeira-de-Araújo A, Bernardo-Filho M. 2001. Effect of the Cymbopogon citratus, Maytenus ilicifolia and Baccharis genistelloides extracts against the stannous chloride oxidative damage in Escherichia coli. Mutat. Res. 496: 33-38.
37. Mitić-Ćulafić C, Žegura B, Nikolić B, Vuković-Gačić B, Knežević-Vukčević J, Filipič M. 2009. Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells. Food Chem. Toxicol. 47: 260-266.
38. Negrelle RRB, Gomes EC. 2007. Cymbopogon citratus (DC.) Stapf: chemical composition and biological activities. Rev. Bras. Pl. Med. 9: 80-92.
39. NTP. 2003. Toxicology and Carcinogenesis Studies of Citral (Microencapsulated) (CAS no. 5392-40-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Technical Report Series 505.
40. Oliveira VC, Moura DM, Lopes JA, de Andrade PP, da Silva NH, Figueiredo RC. 2009. Effects of essential oils from Cymbopogon citratus (DC) Stapf., Lippia sidoides Cham., and Ocimum gratissimum L. on growth and ultrastructure of Leishmania chagasi promastigotes. Parasitol. Res. 104: 1053-1059.
41. Pereira RP, Fachinetto R, Prestes AS, Puntel RL, Silva GNS, Heinzmann BM, Boschetti TK, Athayde ML, Bürger ME, Morel AF, Morsch VM, Rocha JB.2009. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. Neurochem. Res. 34: 973-983.
42. Pitot HC. 2007. Adventures in hepatocarcinogenesis. Annu. Rev. Pathol. 2: 1-29.
43. Puatanachokchai R, Kishida H, Denda A, Murata N, Konishi Y, Vinitketkumnuen U, Nakae D. 2002. Inhibitory effects of lemon grass (Cymbopogon citratus, Stapf) extract on the early phase of hepatocarcinogenesis after initiation with diethylnitrosamine in male Fischer 344 rats. Cancer Lett. 183: 9-15.
44. Rabbani SI, Devi K, Khanam S, Zahra N. 2006. Citral, a component of lemongrass oil inhibits the clastogenic effect of nickel chloride in mouse micronucleus test system. Pak. J. Pharm. Sci. 19: 108-113.
45. Raju J. 2008. Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer. World J. Gastroenterol. 14: 6632-6635.
46. Rao BS, Shanbhoge R, Rao BN, Adiga SK, Upadhya BK, Kumar MR. 2009. Preventive efficacy of hydroalcoholic extract of Cymbopogon citrates against radiation-induced DNA damage on V79 cells and free radical scavenging ability against radicals generated in vitro. Hum. Exp. Toxicol. 28: 195-202.
47. Ribeiro, LR, Salvadori DMF. 2003. Dietary components may prevent mutation-related diseases in humans. Mutat. Res. 544: 195-201.
48. Rodrigues MAM, Silva LAG, Salvadori DMF, Camargo JLV, Montenegro MR. 2002. Aberrant crypt foci and colon cancer: comparison between a short- and medium term bioassay for colon medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats. Braz. J. Med. Biol. Res. 35: 351-355.
49. Rosenberg DW, Giardina C, Tanaka T. 2009. Mouse models for the study of colon carcinogenesis. Carcinogenesis 30: 183-196.
50. Santoro GF, Cardoso MG, Guimarães LG, Freire JM, Soares MJ. 2007. Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida). Parasitology 134: 1649-1656.
51. Schaneberg BT, Khan IA. 2002. Comparison of extraction methods for marker compounds in the essential oil of lemon grass by GC. J. Agric. Food. Chem. 50: 1345-1349.
52. Silva MR, Ximenes RM, da Costa JG, Leal LK, de Lopes AA, de Barros Viana GS. 2010. Comparative anticonvulsant activities of the essential oils (EOs) from Cymbopogon winterianus Jowitt and Cymbopogon citratus (DC) Stapf. in mice. Naunyn Schmiedebergs Arch. Pharmacol. 381: 415-426.
53. Stoner GD, Morse MA, Kelloff GJ. 1997. Perspectives in cancer chemoprevention. Environ. Health Perspect. 105: 945-954.
54. Suaeyun R, Kinouchi T, Arimochi H, Vinitketkumnuem U, Ohnishi Y. 1997. Inhibitory effects of lemon grass (Cymbopogon citratus, Stapf) on formation of azoxymethane-induced DNA adducts and aberrant crypt foci in the rat colon. Carcinogenesis 18: 949-955.
55. Tapia A, Cheel J, Theoduloz C, Rodríguez J, Schmeda-Hirschmann G, Gerth A, Wilken D, Jordan M, Jiménez-González E, Gomez-Kosky R, Mendoza EQ. 2007. Free radical scavengers from Cymbopogon citratus (DC.) STAPF plants cultivated in bioreactors by the temporary immersion (TIS) principle. Z. Naturforsch. C 62: 447-457.
56. Thompson HJ, Singh M. 2000. Rat models of premalignant breast disease. J. Mammary Gland Biol. Neoplasia 5: 409-420.
57. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC, Sasaki YF. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35: 206-221.
58. Van Zeeland AA, de Groot AJ, Mohn GR, van Steeg H, van Oostrom C, van Duijn-Goedhart AM, Mullenders LF, Jansen JG. 2008. Reduced methylation-induced mutagenesis in rat splenocytes in vivo by sub-chronic low dose exposure to N-metyl-N-nitrosourea. Mutat. Res. 640: 131-138.
59. Vinitketkumnuen U, Puatanachokchai R, Kongtawelert P, Lertprasertsuke N, Matsushima T. 1994. Antimutagenicity of lemon grass (Cymbopogon citratus Stapf) to various known mutagens in salmonella mutation assay. Mutat. Res. 341: 71-75.
60. Wargovich MJ, Medline A, Bruce WR. 1983. Early histopathologic events to evolution of colon cancer in C57BL/6 and CF1 mice treated with 1, 2-dimethylhydrazine. J Nat. Cancer Inst. 71: 125-131.
61. Williams GM. 1999. Chemically-induced preneoplastic lesions in rodents as indicators of carcinogenic activity. In The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation, McGregor DB, Rice JM, Venitt S (eds). IARC Scientific Publication no. 146. IARC: Lyon; 185-202.
62. Yamada Y, Mori H. 2003. Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 24: 1015-1019.
63. Zamith HP, Vidal MN, Speit G, Paumgartten FJ. 1993. Absence of genotoxic activity of beta-myrcene in the in vivo cytogenetic bone marrow assay. Braz. J. Med. Biol. Res. 26: 93-98.
64. Zapaterini JR, Bidinotto LT, Rodrigues MA, Barbisan LF. 2010. Chemopreventive effects of mate against mouse mammary and colon carcinogenesis. Hum. Exp. Toxicol. 29: 175-185.